
BYK204165
CAS No. 1104546-89-5
BYK204165( RT-017290 )
Catalog No. M21123 CAS No. 1104546-89-5
BYK204165 is a potent PARP inhibitor?(PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 58 | Get Quote |
![]() ![]() |
10MG | 87 | Get Quote |
![]() ![]() |
25MG | 192 | Get Quote |
![]() ![]() |
50MG | 286 | Get Quote |
![]() ![]() |
100MG | 426 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBYK204165
-
NoteResearch use only, not for human use.
-
Brief DescriptionBYK204165 is a potent PARP inhibitor?(PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).
-
DescriptionBYK204165 is a potent PARP inhibitor?(PARP1; IC50 = 44.67 nM for human recombinant PARP1 in an enzyme assay).
-
In Vitro——
-
In Vivo——
-
SynonymsRT-017290
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1104546-89-5
-
Formula Weight252
-
Molecular FormulaC15H12N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (495.50 mM; Need ultrasonic)
-
SMILESCn1cccc1C=C1C(=O)NC(=O)c2ccccc21
-
Chemical Name(4Z)-4-[(1-methylpyrrol-2-yl)methylidene]isoquinoline-13-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Eltze T Boer R Wagner T et al. Imidazoquinolinone imidazopyridine and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.[J]. molecular pharmacology 2008 74(6):1587-1598.
molnova catalog



related products
-
PARP1-IN-8?
PARP1-IN-8 is an effective inhibito of PARP1 (IC50 = 97 nM).
-
4-amino-1,8-Naphthal...
4-amino-1,8-Naphthalimide (4-ANI) is a PARP inhibitor with IC50 of 180 nM.
-
UNBS-5162
UNBS-5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.